Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CNSPthis companyCNS Pharmaceuticals, Inc.	$4.16	-0.15×	0.51×	0×	0.29×	75.0%	0.0%	0.0%	0.0%	-350.5%	-329.5%	-594.1%	0.07×	0.43×	-1,049.68×	1.98×	0.0%	1	-7.36	2	C+
ENSCEnsysce Biosciences, Inc.	$0.36	-0.23×	0.73×	0×	0.16×	-85.7%	0.0%	0.0%	0.0%	-316.6%	-320.9%	-337.1%	0.1×	0.39×	-545.69×	1.59×	0.0%	3	-82.13	2	C+
GRIGRI Bio, Inc.	$1.86	-0.06×	0.11×	0×	0.62×	4375.4%	0.0%	0.0%	0.0%	-199.0%	-197.0%	-1502.1%	0.01×	0.68×	0×	3.25×	0.0%	1	-6.79	3	B
KTTAPasithea Therapeutics Corp.	$0.57	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
OGENOragenics, Inc.	$0.36	-0.17×	0.2×	0×	-0×	319.2%	0.0%	0.0%	0.0%	-118.9%	-108.5%	-547310.7%	0.03×	-0.01×	-11.91×	5.64×	0.0%	1	-63.79	2	C+
SILOSilo Pharma, Inc.	$1.63	-0.68×	0.45×	39.53×	0.45×	443.7%	-1128.9%	-5937.0%	-5863.5%	-67.0%	-61.5%	-163.6%	0×	1.14×	-114.76×	11.36×	0.0%	1	-6	2	C+
Peer median	—	-0.23×	0.2×	0×	0.45×	443.7%	0.0%	0.0%	0.0%	-118.9%	-108.5%	-337.1%	0.01×	0.68×	-11.91×	5.64×	0.0%	1	-6.79	2	—